Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-response of FE 999049 in Ovarian Stimulation
NCT01426386Phase 2Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Sep 2011
- Primary completion
- Apr 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
A Phase 2 trial of follitropin delta in infertility, sponsored by Ferring Pharmaceuticals. Started Sep 2011; status: completed.
02
Drugs
follitropin delta
03
Conditions
infertility
Beyond the preview
Go deeper on NCT01426386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01426386.